June - 2021

top of page

Sage Group News

The Sage Group Represents VAL401 - A Unique Formulation of Respiridone for Cancer Supportive Care

The Sage Group Represents VAL401 - A Unique Formulation of Respiridone for Cancer Supportive Care

The Sage Group Represents VAL401 - A Unique Formulation of Respiridone for Cancer Supportive Care

The Sage Group is working with UK-based ValiRx, which is developing a unique, patented, cancer supportive care product, VAL401, for which...

bottom of page